- Reuters•4 days ago
Gains in major healthcare and consumer goods stocks propped up European equities on Tuesday, offsetting persistent concerns over the region's banking system. The pan-European STOXX 600 index edged up 0.1 ...
- Market Realist•last month
Novo Nordisk (NVO) operates in two major segments: diabetes and obesity care and biopharmaceuticals. Diabetes care has been Novo’s major business area.
Novo Nordisk A/SCopenhagen
|52wk Range||305.10 - 415.00|
|Day's Range||376.40 - 380.60|
|Avg Vol (3m)||2,294,315|
As of 10:59 AM EDT. Market closed.